In a scathing letter to directors, Privet Fund LP said accountability is sorely lacking throughout the upper ranks of the company, which has a stock price languishing below $2 a share.
Internet behemoth IAC appears bent on hashing out an acquisition and likely would stage a hostile takeover if Angie’s List resists, market analysts say.
A strong third quarter prompted Simon to boost its earnings forecast and raise its quarterly dividend to $1.60 per share, a 23.1 percent year-over-year increase.
Shares sank 15 percent on Wednesday morning despite an $82,000 profit in the third quarter. New CEO Scott Durchslag told analysts he wanted to increase shareholder value organically rather than pursue a sale or merger.
Analysts have consistently given the Indianapolis-based company some of the lowest ratings among a group of 16 large drugmakers, but Lilly shares have been on a five-year rally.
Analysts say the hiring of Scott Durchslag suggests Angie’s List is intent on a turnaround and not a sale. The new CEO shared his vision Tuesday.
Now with a 9-percent stake, New York-based TCS Capital Management says it’s after multiple board seats and plans to continue discussing options to maximize the firm’s value, including a sale.
A wave of fear triggered by instability in China initially doused U.S. stocks on Monday morning, but then quickly receded by noon.
The retailer reported another lackluster quarter with sales dips in every category except home products. But its shares shot up in trading because the results were better than expected.
The stock price for Cigna Corp. remained lethargic during trading Thursday, as another mega-merger of insurers complicated the Anthem deal and sparked antitrust concerns.
Shares of Eli Lilly and Co. stagnated in Wednesday morning trading as investors and patients wished that the effects of solanezumab were more pronounced. Rival Biogen offered muddy results from its own Alzheimer’s drug.
If true, the move could signal that Indianapolis-based Simon Property Group no longer is interested in acquiring the rival shopping-mall owner.
HHGregg Inc. has tried for four years to reverse sliding sales. That hasn’t worked, and now executives have turned their focus to slashing expenses in a quest to return to profitability next year.
Reducing expenses and rejiggering inventory helped the Indianapolis-based retailer of athletic apparel finish a disappointing year with a strong kick.
The Indianapolis-based manufacturer had sales of $544.4 million in its fourth quarter, an 11-percent increase over the same period of 2013. Profit rose to $50.5 million, up from $42.9 million.
CNO Financial Group looks nothing like it did five years ago. CNO stock recently traded around $17.50 a share, led in part by five consecutive years of profit. It has sold or spun off the last of its risky books of business acquired during go-go years, and it’s on the cusp of a significant bond-rating milestone.